Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Hendifar

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Oncotarget|November 7, 2019
Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterationsJun Gong, Edik M Blais, Joseph R Bender, et al.
Frontiers in Oncology|January 23, 2023
Multitasking dynamic contrast enhanced magnetic resonance imaging can accurately differentiate chronic pancreatitis from pancreatic ductal adenocarcinomaNan Wang, Srinivas Gaddam, Yibin Xie, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 18, 2021
Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasisVeronica R Placencio-Hickok, Marie Lauzon, Natalie Moshayedi, et al.
Biomedicines|May 27, 2023
Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study ProtocolJun Gong, Arsen Osipov, Jeremy Lorber, et al.
NPJ Precision Oncology|February 15, 2024
Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgeryStephanie N Shishido, Emmeline Lin, Nicholas Nissen, et al.
Advances in Radiation Oncology|March 29, 2024
Patterns of Failure in Patients With Borderline Resectable/Locally Advanced Pancreatic Cancer After Preoperative Chemotherapy and Stereotactic Body Radiation TherapyEric M Chung, Diana J Lu, Anthony T Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2014
Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcomaSant P Chawla, Lee D Cranmer, Brian A Van Tine, et al.
Pancreas|March 6, 2020
Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy: A Systematic Literature ReviewTeresa Macarulla, Andrew E Hendifar, Chung-Pin Li, et al.
Cancer Medicine|September 3, 2021
Leveraging patient-reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experienceArjun Gupta, Omar Khalid, Cassadie Moravek, et al.
Frontiers in Oncology|August 2, 2021
Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal IrinotecanKenneth H Yu, Andrew E Hendifar, Olatunji B Alese, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Oncotarget|November 7, 2019
Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterationsJun Gong, Edik M Blais, Joseph R Bender, et al.
Frontiers in Oncology|January 23, 2023
Multitasking dynamic contrast enhanced magnetic resonance imaging can accurately differentiate chronic pancreatitis from pancreatic ductal adenocarcinomaNan Wang, Srinivas Gaddam, Yibin Xie, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 18, 2021
Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasisVeronica R Placencio-Hickok, Marie Lauzon, Natalie Moshayedi, et al.
Biomedicines|May 27, 2023
Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study ProtocolJun Gong, Arsen Osipov, Jeremy Lorber, et al.
NPJ Precision Oncology|February 15, 2024
Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgeryStephanie N Shishido, Emmeline Lin, Nicholas Nissen, et al.
Advances in Radiation Oncology|March 29, 2024
Patterns of Failure in Patients With Borderline Resectable/Locally Advanced Pancreatic Cancer After Preoperative Chemotherapy and Stereotactic Body Radiation TherapyEric M Chung, Diana J Lu, Anthony T Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2014
Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcomaSant P Chawla, Lee D Cranmer, Brian A Van Tine, et al.
Pancreas|March 6, 2020
Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy: A Systematic Literature ReviewTeresa Macarulla, Andrew E Hendifar, Chung-Pin Li, et al.
Cancer Medicine|September 3, 2021
Leveraging patient-reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experienceArjun Gupta, Omar Khalid, Cassadie Moravek, et al.
Frontiers in Oncology|August 2, 2021
Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal IrinotecanKenneth H Yu, Andrew E Hendifar, Olatunji B Alese, et al.
Pageof 9